Faron Pharmaceuticals reports new data for cancer drug Clevegen
Faron Pharmaceuticals has reported new findings from the open-label Phase I/II MATINS clinical trial of...
Faron says treatment for ARDS shows no improvement versus placebo
Faron Pharmaceuticals said clinical results from a study for the treatment of acute respiratory distress...
Bayer and Orion report positive data from trial of darolutamide
Bayer and Orion have reported positive results from a Phase III clinical trial (ARAMIS) of...
Deals this week: DelSiTech, Marken, Erasca
DelSiTech has signed an agreement with Innovare for the development of long-acting human immunodeficiency virus (HIV)...
Deals this week: Zealand Pharma, Fulcrum Therapeutics, Forendo Pharma
Zealand Pharma has sold its future royalty streams and potential commercial milestones for Soliqua® 100/33/Suliqua®...
M&As this week: Tongyang, Glenmark Pharmaceuticals, Leerink Revelation Partners
Tongyang Networks Corporation has acquired a 29.72% stake in biotechnology company MediGene for KRW30.3bn ($28.02m).